Evaluation of MST-188 in Acute Lower Limb Ischemia

NCT02093468 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

4

Enrollment

INDUSTRY

Sponsor class

Stopped Program discontinued to persue alternate indications.

Conditions

Acute Limb Ischemia

Interventions

DRUG: MST-188
DRUG: Saline

Sponsor

Mast Therapeutics, Inc.